kabutan

Kidswell Bio, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Increases by 64%

Wed Feb 12, 2025 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE Growth] announced its financial results after the market closed on February 12th (16:00). The consolidated net loss for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was a reduced loss of 187 million yen (compared to a loss of 747 million yen in the previous period non-consolidated).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the January to March period (4Q) is expected to expand to a loss of 763 million yen (compared to a loss of 675 million yen in the previous period non-consolidated).

In the most recent three-month period, from October to December (3Q), the consolidated net income increased 63.6% from the same period last year, reaching 54 million yen. The operating profit margin significantly improved from 5.3% in the same period last year to 9.7%.

Note: Since the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2022 1,726 -135 -194 -194 -6.2 ー Feb 7, 2023 J-GAAP
Apr - Dec, 2023 1,566 -667 -712 -747 -21.8 ー Feb 7, 2024 J-GAAP
Apr - Dec, 2024 3,036 -137 -161 -187 -4.7 ー Feb 12, 2025 J-GAAP
YoY +93.9% +79.5% +77.4% +75.0% +78.5%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 1,850 -616 -645 -642 -18.2 0 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 2,251 -738 -733 -709 -16.5 0 Nov 12, 2024 J-GAAP
YoY +21.7% -19.8% -13.6% -10.4% +9.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,776 -550 -624 -657 -20.8 0 May 12, 2023 J-GAAP
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 Guidance 4,000 -1,000 -1,000 -950 -22.1 0 Nov 12, 2024 J-GAAP
YoY +64.5% +25.1% +28.0% +33.2% +45.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 985 52 32 33 1.0 5.3 Feb 7, 2024 J-GAAP
Jan - Mar, 2024 865 -668 -677 -675 -19.1 -77.2 May 14, 2024 J-GAAP
Apr - Jun, 2024 482 -158 -176 -176 -4.5 -32.8 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 1,267 -104 -91 -65 -1.6 -8.2 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 1,287 125 106 54 1.4 9.7 Feb 12, 2025 J-GAAP
YoY +30.7% +140.4% +231.3% +63.6% +40.6%

Related Articles